EchoLaser for benign prostate enlargement: how does it work?

Written in association with: Mr Wissam Abou-Chedid
Published:
Edited by: Aoife Maguire

Benign prostatic enlargement, also known as benign prostatic hyperplasia (BPH), is a prevalent condition in men, especially as they age. The prostate, a small gland located below the bladder, encircles the urethra—the tube that carries urine out of the body. As the prostate enlarges, it can compress the urethra, leading to urinary difficulties such as a weak urine stream, trouble initiating urination, and frequent urination, particularly at night. While BPH is not cancerous, it can severely impact a man's quality of life by disrupting sleep, causing discomfort, and increasing the risk of urinary tract infections.

 

Leading consultant urological surgeon, Mr Wissam Abou-Chedid, provides insight into a cutting-edge treatment option: EchoLaser, a non-invasive and highly effective method for treating BPH.

 

 

What Is EchoLaser laser treatment?

 

EchoLaser is an innovative, micro-invasive procedure designed to reduce the size of the prostate and alleviate the symptoms of BPH. Utilising laser energy, EchoLaser achieves a significant reduction in prostate volume, thereby relieving the pressure exerted on the urethra. This helps to restore normal urinary flow, providing a gradual but noticeable resolution of symptoms.

 

Patients who undergo EchoLaser treatment typically experience an improvement in their quality of life, marked by a stronger urine stream and fewer trips to the bathroom—especially at night. The procedure allows men to resume normal activities quickly without the extended downtime or risks associated with traditional surgery.

 

How does the procedure work?

 

EchoLaser treatment uses low-power laser energy, typically 3 watts, delivered over a few minutes. During the procedure, laser radiation is transmitted via optical fibers, which are inserted through fine 21G needles (less than one millimeter in diameter) into the prostate transperineally (through the skin between the anus and scrotum).

 

This precision-guided laser energy heats and destroys the targeted prostate tissue. Over the course of a few weeks, the treated tissue is naturally absorbed by the body, resulting in a reduction in prostate volume and an alleviation of symptoms.

 

Patients typically begin to experience symptomatic relief within days, with improvement continuing as the body reabsorbs the treated tissue. The results of EchoLaser treatment are not only swift but also long-lasting, making it a highly effective option for BPH management.

 

Who is a good candidate for EchoLaser treatment?

 

EchoLaser therapy is ideally suited for men experiencing moderate to severe symptoms of BPH. It is particularly beneficial for individuals who have found medication ineffective or intolerable due to side effects. For men seeking a minimally invasive treatment option, EchoLaser offers significant advantages: quicker recovery times, minimal risks, and fewer complications when compared to traditional surgical procedures.

 

However, EchoLaser may not be suitable for everyone. Men with particularly large prostates or certain underlying medical conditions may require alternative treatments. A comprehensive consultation with a urologist is essential to determine whether EchoLaser is the best course of action based on individual medical circumstances.

 

What are the potential benefits and risks?

 

Primary benefits of EchoLaser treatment include:

 

  • Minimally invasive: EchoLaser is a micro-invasive procedure performed through fine needles, minimising discomfort and the risk of complications.
  • Quick recovery: The procedure is typically done under local anesthesia, allowing for faster recovery and reducing the need for an extended hospital stay.
  • Preservation of sexual function: Unlike some surgical options, EchoLaser has minimal to no impact on sexual function, preserving erectile and ejaculatory abilities.
  • Immediate symptom relief: Many patients begin to experience symptom relief within days, with continued improvement over time.
  • Reduced risk of complications: With its targeted approach, EchoLaser treatment significantly lowers the risks of complications such as incontinence, which can be more common in traditional prostate surgeries.

 

What are the potential risks?

 

While EchoLaser is generally safe, as with any medical procedure, there are some risks to consider:

 

  • Temporary urinary discomfort: Some patients may experience mild discomfort or difficulty urinating immediately following the procedure. This is typically short-lived.
  • Risk of urinary tract infection (UTI): As with any procedure involving the urinary system, there is a small risk of developing a UTI.
  • Minor bruising or swelling: The insertion of needles may result in temporary bruising or swelling in the treated area.

 

Despite these risks, EchoLaser is considered a safe and effective treatment option for BPH, offering significant relief without the more invasive nature of traditional surgeries.

 

Is EchoLaser right for you?

 

If you are experiencing moderate to severe BPH symptoms that are no longer well-managed by medication, or if you're seeking a minimally invasive solution with quicker recovery and fewer side effects, EchoLaser may be the ideal option. Consult with a qualified urologist like Mr Wissam Abou-Chedid to explore whether this innovative treatment could help improve your quality of life.

By Mr Wissam Abou-Chedid
Urology

Mr Wissam Abou-Chedid earned his medical degree from the University of Saint Joseph in Beirut before completing his urology specialist training at Henry Mondor University Hospital in Paris. He further honed his skills through fellowships in minimally invasive and robotic surgery at Saint Augustin Clinic in Bordeaux and the Royal Surrey NHS Foundation Trust in Guildford.

He was then appointed as a consultant urological surgeon at the Royal Surrey NHS Foundation Trust in February 2022. His robust academic background, including multiple postgraduate diplomas in Andrology, Laparoscopic surgery, urodynamics and pelviperineology, a master's degree in biomedical sciences and a fellowship from the Royal College of Surgeons of Edinburgh, provides a solid foundation for his work.

Mr Wissam Abou-Chedid has distinguished himself as a leader in the field, particularly in robotic-assisted surgery and minimally invasive procedures for prostate cancer and benign prostatic enlargement. His exceptional track record is marked by his significant contribution to the volume of surgeries performed, with over 500 cases completed in the last two years alone, making him one of the highest-volume consultants for robotic prostate surgery in the UK during that period.

Beyond sheer volume, Mr Abou-Chedid's expertise extends to specialised techniques, notably in retzius sparing prostatectomy, where he is recognised as one of the highest-volume surgeons in Europe. This recognition underscores his proficiency in advanced surgical methods that prioritize patient outcomes and quality of life. In addition to his clinical practice, Mr Abou-Chedid serves as a robotic and minimal invasive urological surgery trainer at IRCAD, a renowned international center for research and training in minimally invasive surgery.

Here, he shares his extensive knowledge and skills with surgeons from around the world, emphasizing the importance of adopting the latest technologies and techniques to achieve optimal patient outcomes. Mr Abou-Chedid's commitment to innovation is evident in his pioneering work, such as day case robotic prostatectomy and the concept of self-removal of catheters post-prostatectomy. These groundbreaking advancements not only demonstrate his dedication to pushing the frontiers of urological surgery but also highlight his focus on improving patient recovery and quality of life.

Mr Wissam Abou-Chedid is not only dedicated to advancing prostate cancer care but also continually seeks new and modern techniques for the treatment of benign enlargement of the prostate, aiming to improve the quality of life for men experiencing urinary symptoms. Recognizing the importance of staying at the forefront of medical technology, he has championed the use of innovative treatments such as Rezum, Echolaser, Optilume, and Exime, among other cutting-edge technologies. By integrating these advanced methods into his practice, Mr. Abou-Chedid ensures that his patients have access to the most effective and minimally invasive treatments available.

His proactive approach to embracing new technologies underscores his commitment to delivering the highest standard of care and improving outcomes for men with urological conditions. Outside of his professional pursuits, Mr. Abou-Chedid is deeply involved in community outreach programs aimed at raising awareness about prostate cancer screening and prevention. Through these initiatives, he seeks to empower individuals to take charge of their health and advocate for early detection and intervention.

Mr Abou-Chedid's commitment to these causes extends to his active involvement with charities such as Prostate Cancer UK and The Prostate Project. He serves as a Prostate Cancer UK National Clinical Champion, leveraging his expertise to support the organization's mission of providing vital services, raising awareness, and funding research.

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.